(lp0
S'Acura Pharmaceuticals Seeks To Raise $5 Million In Offering Seeking Alpha - Feb 7, 2017 Acura Pharmaceuticals has filed to raise $5 million in a follow-on stock and warrant offering. The company is commercializing tamper-resistant medication technologies, but appears to be running out of money and time.'
p1
aS'Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed ... Yahoo Finance - Mar 17, 2017 PALATINE, Ill., March 17, 2017  -- Acura Pharmaceuticals, Inc.  and MainPointe Pharmaceuticals, LLC today announced that they have entered into a License Agreement  to have MainPointe exclusively market&nbsp;...ACURA PHARMACEUTICALS, INC.  Files An 8-K Entry into a Material ... - Market Exclusive'
p2
aS"Acura Pharmaceuticals Inc. ACUR  Wall Street Journal - Feb 13, 2011 News Acura Pharmaceuticals Inc.ACUR. No news for ACUR in the past two years. Key Stock Data ? P/E Ratio : The Price to Earnings  ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the&nbsp;..."
p3
aS'Acura Pharmaceuticals Inc : Is An Exposure Worth The Risk? Insider Financial - Feb 9, 2017 Acura Pharmaceuticals, Inc. started out this week at circa $0.5 a share. By mid week, it had risen to more than $1.3, and currently trades for just shy of $1.Is Acura Pharmaceuticals, Inc.  in Oversold Territory? - The Oracle ExaminerStocks in the Spotlight: Acura Pharmaceuticals, Inc.  , Ironwood ... - NYSE Journal '
p4
aS'Examining the Numbers on Shares of Acura Pharmaceuticals, Inc.  Baxter Review - 14 hours ago Acura Pharmaceuticals, Inc.  currently has a Gross Margin  ratio of 0.043551. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks.'
p5
aS'Acura Pharmaceuticals, Inc.  To Delist From NASDAQ; Shares Fall 23% Smarter Analyst - Feb 15, 2017 Acura Pharmaceuticals, Inc.  investors are running for the hills, after the drug announced that its shares will be delisted from the NASDAQ Stock Market.'
p6
aS'Stock Update : Acura Pharmaceuticals, Inc. Provides Development ... Smarter Analyst - Dec 14, 2016 Acura Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration  has provided the Company with advice on the continued development of its product candidate LTX-04  which utilizes the&nbsp;...'
p7
aS"Acura Pharmaceuticals'  CEO Bob Jones on Q3 2016 Results - Earnings Call ... Seeking Alpha - Nov 15, 2016 ... to maximize this potential, future product sales, financial results and the company's strategy for near-term financing and long-term growth."
p8
aS'ACURA PHARMACEUTICALS, INC.  Files An 8-K Departure of Directors ... Market Exclusive - Feb 25, 2017 On February 24, 2017, we increased the maximum bonus payable to Albert W. Brzeczko, Vice President Technical Affairs of our subsidiary Acura Pharmaceutical Technologies, Inc. from 35% to 50% of base salary under our non-equity bonus incentive plan.'
p9
aS"Why Pfizer And Publix Will Ramp Up Acura Pharmaceuticals Seeking Alpha - Sep 24, 2013 One such company which has seen recent, dramatic spikes on positive news is Acura Pharmaceuticals . Just pull up a 12 month chart and you will see what I'm talking about."
p10
a.